Dr. Marcus to speak at FDA

On Sept 12 Dr. Marcus is to present at the FDA conference on Cells and Tissues that will help determine the new guidelines on the use of stem cells and growth factors.

Dr. Marcus teaching fall course at Johns Hopkins

This fall semester, Dr. Marcus will once again teach “Funding a New Venture” through the Advanced Acadmeic Programs Department of Johns Hopkins. This is an online course with worldwide participation.

Amniotic Fluid or Stem Cells, or both?

So far the first 11 patients with “amniotic” injections are doing fine, no complications and 10/11 experiencing little if any symptoms; in other words, PRP plus the amniotic fluid appears to be as good as PRP alone. It is still too early to determine if the addition of the amniotic fluid is better than PRP alone. Since this is not a controlled, blinded study, we will have to use prior knowledge and expectations to make a judgement of this kind.

As to the fluid, it contains a variable number of cells that appear in the cell counter as either lymphocytes or granulocytes. As expected, quality control of cell number is problematic and is not being done at the tissue bank on each lot. We are in the process of analyzing the growth factors in the fluid, which of course may be equally or more important than the cells. Stay tuned.

Entrepreneurship and Engineering

Dr. Marcus to teach E & E at George Mason University this Spring Semester 2016.

Hexcite Lecture at Johns Hopkins

On Fri Nov 13 Dr. Marcus spoke to the entrepreneurs at Johns Hopkins Medical School about concepts in funding new ventures. The Group is Called Hexcite!

Amniotic Stem Cell Therapy Now available

We now have access to a source of stem cells derived from healthy deliveries (C sections) and screened thoroughly by an accredited tissue bank. These are allograft cells, meaning, from a different person, and do not require tissue matching because they do not possess immunogenic surface antigens.  The cells arrive frozen in dry ice, and must be used on the day of arrival. The present plan is to combine the cells with the growth factors of PRP. The cost of these cells is moderate, especially compared with charges for bone marrow aspirate that are offered in other centers.

Please inquire if this exciting new addition to our technology is of interest to you.

July 9 Talk

Dr. Marcus will be in Stuart Florida to talk about Surface and Sub-surface reconstruction of the damaged joint.

Dr. Marcus to speak at Cherry Blossom Orthopedic Seminar

April 5, Waterview Conference Center

Rosslyn Va


Topic: Juvenile Allograft for Cartilage Reconstruction

Sanibel Symposium

Dr. Marcus is to speak on the role of PRP and Cartilage Repair at the forthcoming Sanibel  Perfusion Symposium, Ft. Myers Fla.

Feb 15, 2014.

Dr. Marcus Receives Honor from International Cartilage Repair Society

Dr. Marcus was elected as a Senior Fellow and Honorary member of the ICRS (International Cartilage Repair Society) in recognition of his contributions

to the field and for being a thought leader in cartilage repair.